Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
acute, adjunctive, Africa, ANVISA, ASRT, Assertio, Brazilian, Chemistry, CMC, Committee, context, convulsive, declared, East, England, faster, frequent, important, inapplicability, inducement, intermittent, light, likelihood, middle, Norway, Ondif, Otter, pattern, Pharmanovia, plasma, prolonged, proposed, PTO, repetitive, Serial, stereotypic, Switzerland, systolic, tentative, thirty, Valtoco, withholding
Removed:
addressed, begin, community, Concurrently, CRL, demonstrate, device, ease, establishing, evolve, fall, finalization, focusing, goal, grow, growing, home, landscape, language, local, modeling, move, online, opportunity, pace, payer, PDUFA, pharmacy, pivotal, prescriber, Prescription, rationalization, reestablish, relation, remotely, responding, resubmission, resubmitted, shortly, spend, staffing, step, strong, superiority, supplementing, supporting, tested, Type, underway, User, vaccination, working
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view